Saskia Bolz - Concepedia

Author

Saskia Bolz

Essen University Hospital ORCID

Also Known As

S Bolz, S Bölz, S. Bolz, Saskia Bolz

Publications

394

Citations

H-Index

Concepts

All Affiliations

Essen University Hospital Institut für Medizinische Informatik, Biometrie und Epidemiologie German Cancer Research Center Deutschen Konsortium für Translationale Krebsforschung University of Duisburg-Essen

About

Saskia Bolz is an author at Essen University Hospital specializing in neurology, medicine, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	48
2	Neurology	1	1	48
3	Neuroscience	1	1	48
4	Neurodegenerative Diseases	1	1	48
5	Neuromuscular Pathology	1	1	48

Saskia Bolz

Publications

382

Citations

H-Index

Page 1

	Year	Citations
Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy Benjamin Stolte, Andreas Totzeck, Kathrin Kizina, Therapeutic Advances in Neurological Disorders	2018	84
Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy Benjamin Stolte, J Bois, Saskia Bolz, European Journal of Neurology	2020	50
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with Nusinersen Andreas Totzeck, Benjamin Stolte, Kathrin Kizina, International Journal of Molecular Sciences Neuron-specific EnolaseNeurodegenerative DiseasesAmyotrophic Lateral SclerosisSpinal Cord InjuryTau Protein Are	2019	48
Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters Benjamin Stolte, Michael Nonnemacher, Kathrin Kizina, Journal of Neurology	2021	40
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy Kathrin Kizina, Benjamin Stolte, Andreas Totzeck, Frontiers in Neurology	2019	38
Fatigue in adults with spinal muscular atrophy under treatment with nusinersen Kathrin Kizina, Benjamin Stolte, Andreas Totzeck, Scientific Reports	2020	33
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study Andreas Totzeck, Elakiya Ramakrishnan, Melina Schlag, Therapeutic Advances in Neurological Disorders	2021	23
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy Saskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, eNeurologicalSci	2021	21
Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy Kathrin Kizina, Yakup Akkaya, Daniel Jokisch, Brain Sciences	2021	18
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors? Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, Journal for ImmunoTherapy of Cancer	2019	15

Page 1